All News

Topical ivermectim provided a good degree of cure in patients with head lice infection with one simple and easy to-use application, according to a study published in the Nov. 1 issue of the New England Journal of Medicine.

FDA has expanded the approved use of oral anticoagulant rivaroxaban (Xarelto, Janssen) to include three new indications: treatment of deep vein thrombosis (DVT), treatment of pulmonary embolism (PE), and reducing the risk of recurrent DVT and PE following initial treatment.

An automated online self-management program may help employees with prehypertension or hypertension achieve adequate blood pressure control, according to a study published in the October issue of American Heart Journal.

Bleeding rates associated with new use of dabigatran (Pradaxa, Boehringer Ingelheim) do not appear to be higher than bleeding rates associated with new use of warfarin, according to an FDA safety review of post-market reports of serious bleeding events.

Two recalled products manufactured by the New England Compounding Center (NECC), Farmingham, Mass., have tested positive for bacterial contamination, according to an FDA update.

Congressman Edward J. Markey (D-Mass.) introduced legislation Nov. 2 that he believes will strengthen FDA's authority to oversee compounding pharmacies.

The United States may be the world's last bastion of customer service. Inherent in our national psyche is the expectation that when we pull out our wallets to purchase something, whether a product or a service, we have a right to satisfaction.

A look at how both chain pharmacies and independents are working on providing better diabetes care.

Metformin is one of the most important pharmacologic agents for diabetes, but patients need more to maintain optimal HbA1c levels.

Blood glucose control is the focus of diabetes care, but a holistic approach is needed to meet all of a patient's needs.

Blood glucose meters have come a long way and the newest models can track patterns, in addition to the standard monitoring.

This Nov. 10 marks the 40th anniversary of the pharmacy stamp that was issued to commemorate the profession.

The safe disposal of drugs helps more than just patients.

Medication therapy management offers pharmacists a chance to provide more patient care. MTM also provides a way to compensate pharmacists for these services.

A pharmacist muses on how being successful can lead to not questioning the status quo.

FDA approved a single shared Risk Evaluation and Mitigation Strategy (REMS) for all mycophenolate-containing prescription drugs at the end of September.

The results of a recent survey may come as no surprise to many pharmacists-that time constraints can have an effect on the community practice setting and patient safety.

The Massachusetts Department of Health (DPH) announced Oct. 28 at a press conference that it will be adding five more inspectors to the Board of Pharmacy to continue its investigation of the New England Compounding Center, the Ameridose pharmacy, and other unannounced inspections at compounding pharmacies that prepare sterile injectables.

Cleansing laxatives approved for prescription use before colonscopy

A round-up of OTC products that help lips brave the winter weather.

A pharmacist describes an evening that he feels is typical of being a pharmacist and crystalizes how pharmacists are important.

Is your health system is having an epidemic of CLABSIs? CUSP can help save lives and money.

FDA and the CDC confirm that the fungus Exserohilium rostratum contaminated one of the three implicated lots of preservative-free methylprednisone acetate (80 mg/mL) from the New England Compounding Center which the company recalled September 26.

A look at how technology is changing the treatment of diabetes.

Anticoagulation therapies reviewed, including Merck moving forward with FDA approval of vorapaxar despite bleeding risks

A pharmacist reveals that the solution to all of pharmacy's problems: You get what you pay for.

A survey of new Rx, new generic, and new OTC products

Numerous health and safety violations related to the practice of pharmacy at the New England Compounding Center have been documented by investigators from the Massachusetts Department of Public Health and FDA.